Jin Won Kim

9.5k total citations · 2 hit papers
245 papers, 4.5k citations indexed

About

Jin Won Kim is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Jin Won Kim has authored 245 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Oncology, 95 papers in Pulmonary and Respiratory Medicine and 69 papers in Surgery. Recurrent topics in Jin Won Kim's work include Gastric Cancer Management and Outcomes (52 papers), Colorectal Cancer Treatments and Studies (42 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (40 papers). Jin Won Kim is often cited by papers focused on Gastric Cancer Management and Outcomes (52 papers), Colorectal Cancer Treatments and Studies (42 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (40 papers). Jin Won Kim collaborates with scholars based in South Korea, United States and Japan. Jin Won Kim's co-authors include Jee Hyun Kim, Keun‐Wook Lee, Do‐Youn Oh, Yung‐Jue Bang, Yu Jung Kim, Soo‐Mee Bang, Ji‐Won Kim, Hye Seung Lee, Seock‐Ah Im and Jong Seok Lee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jin Won Kim

229 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A phase 3 randomized, double-blind, placebo-controlled study of durvalumab in combination with gemcitabine plus cisplatin (GemCis) in patients (pts) with advanced biliary tract cancer (BTC): TOPAZ-1.

2022 159 citations Do‐Youn Oh, Jin Won Kim et al. Journal of Clinical Oncology profile →
Kidney Decellularized Extracellular Matrix Enhanced the Vascularization and Maturation of Human Kidney Organoids

2022 124 citations Jin Won Kim, Sun Ah Nam et al. Advanced Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jin Won Kim South Korea	36	2.2k	1.5k	1.3k	1.1k	418	245	4.5k
Kenichi Yoshimura Japan	33	1.7k 0.8×	1.6k 1.1×	1.2k 1.0×	680 0.6×	504 1.2×	247	4.5k
Yanhong Deng China	38	2.3k 1.0×	1.2k 0.8×	1.2k 0.9×	1.2k 1.1×	433 1.0×	284	5.2k
Ji Won Park South Korea	44	3.8k 1.7×	1.6k 1.1×	3.0k 2.4×	1.0k 0.9×	405 1.0×	344	7.4k
Yan‐Shen Shan Taiwan	33	1.7k 0.8×	890 0.6×	1.2k 0.9×	1.4k 1.3×	192 0.5×	216	4.2k
Jean‐Bernard Durand United States	34	2.2k 1.0×	949 0.7×	659 0.5×	1.5k 1.3×	534 1.3×	133	7.0k
Ali Shamseddine Lebanon	39	2.3k 1.1×	1.1k 0.7×	965 0.8×	1.6k 1.5×	583 1.4×	249	5.6k
Hirotoshi Hasegawa Japan	38	2.9k 1.3×	1.3k 0.9×	2.1k 1.6×	538 0.5×	603 1.4×	175	4.6k
Paolo Pedrazzoli Italy	38	1.9k 0.9×	747 0.5×	723 0.6×	960 0.9×	332 0.8×	288	5.5k
Luciano Giacomelli Italy	43	1.4k 0.6×	986 0.7×	2.2k 1.7×	1.5k 1.4×	337 0.8×	247	6.7k
Bengt Gustavsson Sweden	36	2.0k 0.9×	1.7k 1.1×	1.5k 1.2×	1.1k 1.0×	567 1.4×	182	5.4k

Countries citing papers authored by Jin Won Kim

Since Specialization

Citations

This map shows the geographic impact of Jin Won Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin Won Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin Won Kim more than expected).

Fields of papers citing papers by Jin Won Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jin Won Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin Won Kim. The network helps show where Jin Won Kim may publish in the future.

Co-authorship network of co-authors of Jin Won Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Jin Won Kim. A scholar is included among the top collaborators of Jin Won Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jin Won Kim. Jin Won Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Hyung‐Don, Sun Jin Sym, Hong Jae Chon, et al.. (2025). Multicenter single-arm phase II trial of lenvatinib in patients with advanced hepatocellular carcinoma after progression on first-line atezolizumab plus bevacizumab. Journal of Hepatology. 84(2). 308–315. 3 indexed citations

Burns, Christopher J., Terrie‐Anne Cock, Anthony C. Bishop, et al.. (2024). Phase 1b/2a of narmafotinib (AMP945) in combination with gemcitabine and nab-paclitaxel in first-line patients with advanced pancreatic cancer (ACCENT trial): Interim analysis.. Journal of Clinical Oncology. 42(16_suppl). e16337–e16337. 1 indexed citations

Pant, Shubham, Jia Fan, Do‐Youn Oh, et al.. (2024). Zanidatamab in previously-treated HER2-positive (HER2+) biliary tract cancer (BTC): Overall survival (OS) and longer follow-up from the phase 2b HERIZON-BTC-01 study.. Journal of Clinical Oncology. 42(16_suppl). 4091–4091. 11 indexed citations

Lee, Ji Yun, Ju Hyun Lee, Min-Su Kang, et al.. (2024). Skeletal-Related Events in Patients With Multiple Myeloma: A Comprehensive Retrospective Cohort Study. Journal of Korean Medical Science. 39(22). e175–e175. 1 indexed citations

Oh, Soo Jin, Soo Kyung Nam, Keun‐Wook Lee, et al.. (2023). Genomic and Transcriptomic Characterization of Gastric Cancer with Bone Metastasis. Cancer Research and Treatment. 56(1). 219–237. 8 indexed citations

Won, Seung, Jun Suh Lee, Jong-Chan Lee, et al.. (2023). Analysis of Recent Improvement of Survival Outcomes in Patients with Pancreatic Cancer Who Underwent Upfront Surgery. Gut and Liver. 18(4). 737–746. 2 indexed citations

Kang, Min-Su, Koung Jin Suh, Ji‐Won Kim, et al.. (2022). Clinical characteristics and disease course of splanchnic vein thrombosis in gastrointestinal cancers: A prospective cohort study. PLoS ONE. 17(1). e0261671–e0261671. 3 indexed citations

Kim, Jin Won, Sun Ah Nam, Jawoon Yi, et al.. (2022). Kidney Decellularized Extracellular Matrix Enhanced the Vascularization and Maturation of Human Kidney Organoids. Advanced Science. 9(15). e2103526–e2103526. 124 indexed citations breakdown →

Kim, Yu Jung, Sang‐Yeon Suh, Yusuke Hiratsuka, et al.. (2022). Performance of clinician prediction of survival in oncology outpatients with advanced cancer. PLoS ONE. 17(4). e0267467–e0267467. 7 indexed citations

10.

Kim, Se Hyun, Eun Hee Jung, Koung Jin Suh, et al.. (2022). The effect of metformin or dipeptidyl peptidase 4 inhibitors on clinical outcomes in metastatic non‐small cell lung cancer treated with immune checkpoint inhibitors. Thoracic Cancer. 14(1). 52–60. 13 indexed citations

11.

Kim, Hyung‐Don, Myung Ah Lee, Jin Won Kim, et al.. (2020). Regorafenib in patients with advanced Child‐Pugh B hepatocellular carcinoma: A multicentre retrospective study. Liver International. 40(10). 2544–2552. 34 indexed citations

12.

Choi, In Sil, Ju Hyun Lee, Jee Hyun Kim, et al.. (2018). Treatment patterns and outcomes in patients with metastatic gastric cancer receiving third-line chemotherapy: A population-based outcomes study. PLoS ONE. 13(6). e0198544–e0198544. 18 indexed citations

13.

Lee, Yoontaek, Sa-Hong Min, Ki Bum Park, et al.. (2018). Effect of Early Adjuvant Chemotherapy on Survival of Advanced Gastric Cancer Patients: a Propensity Score-matched Analysis. Journal of the Korean Gastric Cancer Association. 18(1). 58–58. 11 indexed citations

14.

Choi, In Sil, Jee Hyun Kim, Ju Hyun Lee, et al.. (2018). A population-based outcomes study of patients with metastatic gastric cancer receiving second-line chemotherapy: A nationwide health insurance database study. PLoS ONE. 13(10). e0205853–e0205853. 8 indexed citations

15.

Min, Ahrum, Seock‐Ah Im, Hyemin Jang, et al.. (2017). AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality with ATM Deficiency in Gastric Cancer Cells. Molecular Cancer Therapeutics. 16(4). 566–577. 105 indexed citations

16.

Bang, Yung‐Jue, Y. Choi, Yeul Hong Kim, et al.. (2017). Efficacy of Sequential Ipilimumab Monotherapy versus Best Supportive Care for Unresectable Locally Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer. Clinical Cancer Research. 23(19). 5671–5678. 113 indexed citations

17.

Ock, Chan-Young, Keun‐Wook Lee, Jin Won Kim, et al.. (2015). Optimal Patient Selection for Trastuzumab Treatment in HER2-Positive Advanced Gastric Cancer. Clinical Cancer Research. 21(11). 2520–2529. 52 indexed citations

18.

Lee, Jeong‐Ok, Ju Hyun Lee, Soyeon Ahn, et al.. (2014). Prevalence and Risk Factors for Iron Deficiency Anemia in the Korean Population: Results of the Fifth Korea National Health and Nutrition Examination Survey. Journal of Korean Medical Science. 29(2). 224–224. 53 indexed citations

19.

Kim, Jin Won, et al.. (2003). Treatment of Unstable Intertrochanteric Femoral Fracture with the AO/ASIF Proximal Femoral Nail (PFN). Journal of the Korean Fracture Society. 16(2). 136–136. 6 indexed citations

20.

Lee, Beom Koo, et al.. (2002). Treatment of Comminuted Fractures of Proximal Tibia using MIPO technique. Journal of the Korean Fracture Society. 15(2). 243–243. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact